Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Recruiting1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
33.3%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (50.0%)
N/A2 (50.0%)

Trials by Status

recruiting120%
completed120%
not_yet_recruiting120%
terminated240%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

NCT07461948
not_yet_recruitingphase_3

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

NCT06448286
completed

A Study of Metabolic Agents Following Brain Radiation

NCT06150547
terminatednot_applicable

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

NCT02269111
terminatednot_applicable

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

NCT01938651

Clinical Trials (5)

Showing 5 of 5 trials
NCT07461948Phase 3

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Recruiting
NCT06448286Phase 3

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Not Yet Recruiting
NCT06150547

A Study of Metabolic Agents Following Brain Radiation

Completed
NCT02269111Not Applicable

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

Terminated
NCT01938651Not Applicable

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

Terminated

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5